Hemmers Injection is NOT Indicated for Antiseizure-Induced Hyperammonemia
For a patient on antiseizure medications (particularly valproate) with progressively increasing ammonia levels, Hemmers injection (furosemide) is not the appropriate treatment and could be harmful. This clinical scenario represents drug-induced hyperammonemic encephalopathy, not fluid overload requiring diuresis.
Understanding the Clinical Context
This patient likely has valproate-induced hyperammonemic encephalopathy, a well-recognized complication where antiepileptic drugs (especially valproate) cause secondary inhibition of the urea cycle 1. The ammonia elevation occurs through competitive inhibition of N-acetylglutamate synthase (NAGS), not through hepatic cirrhosis or fluid retention 1.
Why Hemmers (Furosemide) is Contraindicated
The FDA label for Hemmers explicitly warns that "in hepatic coma and in states of electrolyte depletion, therapy should not be instituted until the basic condition is improved" and that "sudden alterations of fluid and electrolyte balance in patients with cirrhosis may precipitate hepatic coma" 2. While this patient may not have cirrhosis, the principle applies: diuresis can worsen encephalopathy by causing:
- Electrolyte depletion (particularly hypokalemia)
- Metabolic alkalosis (which increases ammonia crossing the blood-brain barrier)
- Volume depletion and azotemia
- Worsening mental status
The Correct Treatment Approach
Immediate Management
Stop the offending antiseizure medication immediately 3, 4. The primary intervention is discontinuation of valproate or other causative agents, as therapeutic drug monitoring may show normal drug levels despite toxic ammonia elevation 3.
Ammonia-Lowering Therapy: L-Ornithine-L-Aspartate (LOLA)
Intravenous L-ornithine-L-aspartate (LOLA) at 30 g/day is the evidence-based treatment for drug-induced hyperammonemia 1, 5. LOLA works by:
- Stimulating the urea cycle through ornithine provision
- Enhancing glutamine synthesis via aspartate
- Activating carbamoyl phosphate synthetase 1 (CPS1)
- Directly detoxifying ammonia through metabolic pathways 6, 7
Clinical evidence demonstrates that IV LOLA reduces ammonia levels and improves mental status in hyperammonemic patients 3, 6, 8. In the specific case of valproate-induced hyperammonemia, LOLA successfully normalized ammonia levels and reversed encephalopathy 3.
Alternative Antiseizure Medication
Replace valproate with levetiracetam or another non-ammoniagenic antiepileptic drug 4. This switch, combined with ammonia-lowering therapy, typically results in:
- Decreased blood ammonia within 5 days
- Improved consciousness level
- Reduced seizure activity
- Clinical stabilization 4
When to Consider Kidney Replacement Therapy
If ammonia levels are severely elevated or refractory to medical management, consider:
- Continuous kidney replacement therapy (CKRT) for ammonia >400 μmol/l (681 μg/dl) refractory to medical measures 1
- Hemodialysis for rapidly deteriorating neurological status with ammonia >150 μmol/l (256 μg/dl) 1
- High-dose CKRT for ammonia >1,000 μmol/l (1,703 μg/dl) 1
These interventions directly remove ammonia from the blood, unlike diuretics which have no role in ammonia clearance.
Critical Monitoring Parameters
Track the following to guide therapy:
- Ammonia levels every 3 hours initially 1
- Mental status using Glasgow Coma Scale or West-Haven criteria 9
- Electrolytes (particularly potassium and bicarbonate)
- Seizure activity
- Response to LOLA therapy (expect improvement within 5 days) 4
Common Pitfalls to Avoid
- Do not use diuretics - They worsen encephalopathy through electrolyte disturbances
- Do not continue valproate - Even with "therapeutic" drug levels, ammonia toxicity can occur 3, 4
- Do not delay ammonia measurement - Normal ammonia essentially rules out hepatic encephalopathy 10
- Do not use oral LOLA - It is ineffective; only IV formulation works 11, 5
- Monitor for polypharmacy risks - Combinations of valproate with topiramate, olanzapine, or quetiapine significantly increase hyperammonemia risk 12
In summary: Hemmers injection has no role in treating antiseizure-induced hyperammonemia and may cause harm. The correct treatment is immediate discontinuation of the offending drug, IV L-ornithine-L-aspartate, and substitution with an alternative antiepileptic medication.